Most of the inflammatory diseases associated with the development of putrefactive processes in human tissues and organs, provokes beta-hemolytic streptococcus, also called pyogenic or pyogenic. Of particular danger are bacteria from the serological group A, as they quickly spread and maintain resistance to different types of antibacterial drugs, even capable of mutating under their influence.
The cause of which pathologies is beta-hemolytic streptococcus group A?
Usually the microbe in question provokes streptococcal tonsillopharyngitis or angina. Specific signs are characteristic for this disease:
- heat, up to 39.2 degrees;
- very severe pain in the throat, up to the violation of the swallowing process;
- intoxication of the body;
- reddening of the posterior pharyngeal walls, palatine arch and tongue;
- puffiness and hyperemia of the tonsils, presence of dense purulent deposits on them;
- increase in regional (nearby) lymph nodes;
- hoarseness of voice.
When diagnosed, beta-hemolytic streptococcus is found in the throat and in the throat.
Tonsillopharyngitis is often accompanied by complications, which are also caused by the described pyogenic bacterium:
- sinusitis;
- paratonzillar abscess ;
- otitis;
- mastoiditis;
- pneumonia;
- meningitis;
- cervical lymphadenitis;
- endocarditis;
- bacteremia.
If a microorganism enters the lymphatic system, it can cause more severe purulent pathologies:
- toxic shock;
- erysipelas;
- Post-streptococcal glomerulonephritis;
- acute rheumatic fever;
- rheumatic heart disease.
Treatment of beta-hemolytic group A streptococcal
Basic therapy of diseases, the causative agent of which is said microbe, is based on the intake of antibacterial agents. Preparations assigned in the first place:
- phenoxymethylpentycline;
- cephalosporins ;
- aminopenicillins.
If a patient suffers from allergic reactions to these types of medications or is infected with a stable form of streptococcus, it is necessary to replace drugs with other antibacterial drugs, macrolides or lincosamides.
An alternative to such "aggressive" treatment are lyophilizates. They are much safer for intestinal microflora, do not harm the immune system and practically do not produce negative side effects.
In world medical practice, such lyophilizates are used:
- Actylase;
- Streptokinase;
- Alteplase;
- IRS-19.